Stockhub

ImmuPharma plc: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

21 September 2022

  • curprev 17:3417:34, 21 September 2022 95.149.241.133 talk 1,259 bytes +1,259 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease. Its other product candi..."
Retrieved from "https://stockhub.co/research/ImmuPharma_plc"